Trademark Overview
On Tuesday, February 13, 2024, a trademark application was filed for MARITIDE with the United States Patent and Trademark Office. The USPTO has given the MARITIDE trademark a serial number of 98404415. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 26, 2024. This trademark is owned by Amgen Inc.. The MARITIDE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development of pharmaceutical preparations; research and development of pharmaceutical preparations in the field of metabolic diseases, namely weight management and diabetes; medical and scientific research information in clinical trials in the field of metabolic diseases, namely weight management and diabetes; providing websites featuring medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of metabolic diseases, namely weight management and diabetes; providing websites featuring medical and scientific research information about pharmaceuticals preparations in the field of metabolic diseases, namely weight management and diabetes; providing websites that features non-downloadable computer software that enables users to access, manage, update and display electronic databases in the field of metabolic diseases, namely weight management and diabetes
